Global Japanese Encephalitis Vaccines Market Growth 2023-2029

Global Japanese Encephalitis Vaccines Market Growth 2023-2029

Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.

LPI (LP Information)' newest research report, the “Japanese Encephalitis Vaccines Industry Forecast” looks at past sales and reviews total world Japanese Encephalitis Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Japanese Encephalitis Vaccines sales for 2023 through 2029. With Japanese Encephalitis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Japanese Encephalitis Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Japanese Encephalitis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Japanese Encephalitis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Japanese Encephalitis Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Japanese Encephalitis Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Japanese Encephalitis Vaccines.

The global Japanese Encephalitis Vaccines market size is projected to grow from US$ 204 million in 2022 to US$ 295.7 million in 2029; it is expected to grow at a CAGR of 295.7 from 2023 to 2029.

United States market for Japanese Encephalitis Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Japanese Encephalitis Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Japanese Encephalitis Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Japanese Encephalitis Vaccines players cover Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, China National Biotec Group and Valneva Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Japanese Encephalitis Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Attenuated Vaccines
Inactivated Vaccines

Segmentation by application
Adults
Children

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
China National Biotec Group
Valneva Products

Key Questions Addressed in this Report

What is the 10-year outlook for the global Japanese Encephalitis Vaccines market?

What factors are driving Japanese Encephalitis Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Japanese Encephalitis Vaccines market opportunities vary by end market size?

How does Japanese Encephalitis Vaccines break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.